Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients.
about
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsMechanisms of disseminated cancer cell dormancy: an awakening fieldThe stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesisTumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in CancerElimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signalingBone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patientsInhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease.Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.Clinical relevance and biology of circulating tumor cells.The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapiesRational Design of Materials Interface for Efficient Capture of Circulating Tumor Cells.New insights into the unfolded protein response in stem cells.Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation.Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications.Plasticity of disseminating cancer cells in patients with epithelial malignancies.Circulating tumor cells as therapy-related biomarkers in cancer patients.Immunogenic, cellular, and angiogenic drivers of tumor dormancy--a melanoma view.Functional studies on circulating and disseminated tumor cells in carcinoma patientsCirculating and disseminated tumor cells: harbingers or initiators of metastasis?CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to MinnelideAdaptive Stress Responses During Tumor Metastasis and Dormancy.Epithelial-mesenchymal plasticity in circulating tumor cells.The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis.Emerging roles of protein disulfide isomerase in cancer.Tumor cell dormancy as an adaptive cell stress response mechanism.The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer.GRP78 and α2-macroglobulin are new promising targets for metastatic castrate-resistant prostate cancer treatment.A facile in vitro platform to study cancer cell dormancy under hypoxic microenvironments using CoCl
P2860
Q26748850-23CEFDB9-55BA-41FB-B414-2CA4F70439C9Q27027015-8EF1F604-CBBA-407A-ACA8-0C6F1F68A8D5Q27319729-ECA76E46-C6BD-424D-98D4-C89CEC5A82A4Q29248711-7CB8952D-E7C9-4154-B0F1-43563874AD88Q34331960-388B32B5-D598-4365-95B5-CE547311DDCEQ34547042-C04554C4-771F-4017-977E-E002EF1D0CA2Q35090829-8220CE25-315B-423C-8095-DF1E7F50AC97Q35579435-ACABBBDC-4C83-472E-9312-E44C5AD3D53AQ35677929-0BFAB1DE-01F5-4BA7-86E7-BA5B34BDBB28Q35889548-B5BE4623-4D30-484F-BFF6-6FF2169A39E4Q37285838-0B7D165C-3D74-4196-A290-1BCAE22AA027Q37422977-9FA9AA29-1B45-43EA-B260-419987908602Q37619863-B65A5CE6-678F-469D-968E-BA17C9F08780Q37695356-FD360BC5-3F8A-4AFD-9891-0057580F4300Q37898107-864D4E7A-4A5B-4286-812D-6B877EDED54DQ38016353-1015AC6E-8770-412B-8EDC-0663C91452EBQ38021683-5CD2C60B-8D61-4D81-9376-C0C30FC356F7Q38073601-B65E0CF1-3AB6-4CD4-B41A-55BF71A0AE5EQ38619615-60F78E7C-E215-4677-8749-0C60E2CA6AF9Q38723767-890D9D22-F86D-4244-B602-731BC7EED867Q38770774-F963D5C4-62FD-48E5-8972-5D2C7398A620Q39014873-D23FDB4C-1DBD-414C-9E9C-D333CD306286Q39014967-3DB9E400-08F1-44EB-A881-F943CCA6396FQ39053335-CE9EB433-6F50-43E8-A5FE-5848F8BEE483Q39409348-869BB11E-9136-40EF-82DA-47F5CBFD9B59Q41953800-C4DDFE59-E385-4B2E-B8CA-BD19810E309AQ42357758-42D7AF35-D30F-4C09-B49E-4305E8DB14BFQ47151754-F528FA39-89B6-4BD6-BA67-4F92F0B9D414Q52608415-0A4B9A1A-F8A6-4F67-B661-E2540B0A5955Q52641574-6D8DFEDF-3222-4693-A7CF-3F1F309EFFE6Q53834602-EA34A952-F248-4363-99F6-6DC9CBAC22ABQ58801300-EC9B478B-AB2D-49FE-A88A-F27118812BEB
P2860
Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Discovery of a novel unfolded ...... row of breast cancer patients.
@ast
Discovery of a novel unfolded ...... row of breast cancer patients.
@en
Discovery of a novel unfolded ...... row of breast cancer patients.
@nl
type
label
Discovery of a novel unfolded ...... row of breast cancer patients.
@ast
Discovery of a novel unfolded ...... row of breast cancer patients.
@en
Discovery of a novel unfolded ...... row of breast cancer patients.
@nl
prefLabel
Discovery of a novel unfolded ...... row of breast cancer patients.
@ast
Discovery of a novel unfolded ...... row of breast cancer patients.
@en
Discovery of a novel unfolded ...... row of breast cancer patients.
@nl
P2093
P356
P1476
Discovery of a novel unfolded ...... row of breast cancer patients.
@en
P2093
Antje Andreas
Friedrich Buck
Jasna Peter-Katalinic
Kai Bartkowiak
Katharina E Effenberger
Klaus Pantel
Sönke Harder
P304
P356
10.1021/PR100039D
P577
2010-06-01T00:00:00Z